TY - JOUR
T1 - Looking inward
T2 - The impact of operative time on graft survival after liver transplantation
AU - Lee, David D.
AU - Li, Jun
AU - Wang, Guihua
AU - Croome, Kristopher P.
AU - Burns, Justin M.
AU - Perry, Dana K.
AU - Nguyen, Justin H.
AU - Hopp, Wallace J.
AU - Taner, C. Burcin
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/10
Y1 - 2017/10
N2 - Background Operative time often has been cited as an important factor for postoperative outcomes. Despite this belief, most efforts to improve liver transplant outcomes have largely focused on only patient and donor factors, and little attention has been paid on operative time. The primary objective of this project was to determine the impact of operative time on graft survival after liver transplant. Methods A retrospective review of 2,877 consecutive liver transplants performed at a single institution was studied. Data regarding recipient, donor, and operative characteristics, including detailed granular operative times were collected prospectively and retrospectively reviewed. Using an instrument variable approach, Cox multivariate modeling was performed to assess the impact of operative time without the confounding of known and unknown variables. Results Of the 2,396 patients who met the criteria for review, the most important factors determining liver transplant graft survival included recipient history of Hepatitis C (hazard ratio 1.45, P =.02), donor age (hazard ratio 1.23, P =.03), use of liver graft from donation after cardiac death donor (hazard ratio 1.50, P <.01), and operative time (hazard ratio 1.26, P =.01). In detailed analysis of stages of the liver transplant operation, the time interval from incision to anhepatic phase was associated with graft survival (hazard ratio 1.33; P =.02). Conclusion Using a novel instrument variable approach, we demonstrate that operative time (in particular, the time interval from incision to anhepatic time) has a significant impact on graft survival. It also seems that some of this efficiency is under the influence of the transplant surgeon.
AB - Background Operative time often has been cited as an important factor for postoperative outcomes. Despite this belief, most efforts to improve liver transplant outcomes have largely focused on only patient and donor factors, and little attention has been paid on operative time. The primary objective of this project was to determine the impact of operative time on graft survival after liver transplant. Methods A retrospective review of 2,877 consecutive liver transplants performed at a single institution was studied. Data regarding recipient, donor, and operative characteristics, including detailed granular operative times were collected prospectively and retrospectively reviewed. Using an instrument variable approach, Cox multivariate modeling was performed to assess the impact of operative time without the confounding of known and unknown variables. Results Of the 2,396 patients who met the criteria for review, the most important factors determining liver transplant graft survival included recipient history of Hepatitis C (hazard ratio 1.45, P =.02), donor age (hazard ratio 1.23, P =.03), use of liver graft from donation after cardiac death donor (hazard ratio 1.50, P <.01), and operative time (hazard ratio 1.26, P =.01). In detailed analysis of stages of the liver transplant operation, the time interval from incision to anhepatic phase was associated with graft survival (hazard ratio 1.33; P =.02). Conclusion Using a novel instrument variable approach, we demonstrate that operative time (in particular, the time interval from incision to anhepatic time) has a significant impact on graft survival. It also seems that some of this efficiency is under the influence of the transplant surgeon.
UR - http://www.scopus.com/inward/record.url?scp=85023772460&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85023772460&partnerID=8YFLogxK
U2 - 10.1016/j.surg.2017.05.010
DO - 10.1016/j.surg.2017.05.010
M3 - Article
C2 - 28684160
AN - SCOPUS:85023772460
SN - 0039-6060
VL - 162
SP - 937
EP - 949
JO - Surgery (United States)
JF - Surgery (United States)
IS - 4
ER -